These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7298287)

  • 1. Chemoimmunotherapy of murine bladder cancer.
    Stogdill BJ; Lamm DL; Livingston RB
    Invest Urol; 1981 Nov; 19(3):179-81. PubMed ID: 7298287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of long-term chemotherapy and/or BCG on murine bladder cancer.
    Soloway MS
    Natl Cancer Inst Monogr; 1978 Dec; (49):327-32. PubMed ID: 748788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of platinum analogues and combination chemotherapy on murine bladder cancer.
    Soloway MS; Cox CE
    Trans Am Assoc Genitourin Surg; 1979; 71():8-13. PubMed ID: 545820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of acetylic salicylic acid and pentoxifylline on the efficacy of intravesical BCG therapy in orthotopic murine bladder cancer (MB49).
    Günther JH; Frambach M; Deinert I; Brandau S; Jocham D; Böhle A
    J Urol; 1999 May; 161(5):1702-6. PubMed ID: 10210443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A murine model for bladder cancer.
    Murphy GP; Sandberg AA; Pontes JE; Ochi H; Yoshida M; Williams PD
    Prog Clin Biol Res; 1984; 162A():177-200. PubMed ID: 6541340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical and systemic chemotherapy of murine bladder cancer.
    Soloway MS
    Cancer Res; 1977 Aug; 37(8 Pt 2):2918-29. PubMed ID: 406041
    [No Abstract]   [Full Text] [Related]  

  • 7. Optimal scheduling of interleukin 12 and chemotherapy in the murine MB-49 bladder carcinoma and B16 melanoma.
    Teicher BA; Ara G; Buxton D; Leonard J; Schaub RG
    Clin Cancer Res; 1997 Sep; 3(9):1661-7. PubMed ID: 9815857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors.
    Sirotnak FM; Otter GM; Schmid FA
    Cancer Res; 1993 Feb; 53(3):587-91. PubMed ID: 8425192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Non-cross-resistant sequential combination chemotherapy consisting of cis-diammine-dichloroplatinum (II) mainly, based on synchronization theory, in human bladder cancer xenografts in athymic nude mice].
    Yamauchi T; Okada K; Yoshida O
    Hinyokika Kiyo; 1986 Dec; 32(12):1781-97. PubMed ID: 2435129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-12 immunotherapy of murine transitional cell carcinoma of the bladder: dose dependent tumor eradication and generation of protective immunity.
    O'Donnell MA; Luo Y; Hunter SE; Chen X; Hayes LL; Clinton SK
    J Urol; 2004 Mar; 171(3):1330-5. PubMed ID: 14767343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.
    Segal R; Winquist E; Lukka H; Chin JL; Brundage M; Markman BR;
    Can J Urol; 2002 Oct; 9(5):1625-33. PubMed ID: 12431323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schedule dependency of the combination methotrexate-vinblastine against human urothelial cancer grown in nude mice.
    Kyriazis AP; Yagoda A; Kyriazis AA
    Anticancer Res; 1989; 9(6):1857-61. PubMed ID: 2627132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of bacillus Calmette-Guérin-induced nitric oxide in bladder tumor cells may improve BCG treatment.
    Alvarez V; Lodillinsky C; Umerez S; Sandes E; Eiján AM
    Int J Mol Med; 2005 Oct; 16(4):565-71. PubMed ID: 16142388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose preoperative systemic cyclophosphamide for the prevention of bladder tumor implantation in F344 rats.
    See WA; Crist SA; Boileau MA; Williams RD
    Cancer Res; 1991 Mar; 51(5):1373-7. PubMed ID: 1997175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effects of polyribonucleotides for mouse transitional cell carcinoma enhanced by cyclophosphamide.
    Borden EC; Sidky YA; Groveman DS; Bryan GT
    Cancer Res; 1985 Jan; 45(1):45-50. PubMed ID: 3965150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative antitumor effects of Corynebacterium parvum, Bordetella pertussis, Bacillus Calmette-Guérin, and levamisole alone or in combination with cyclophosphamide in the CaD2 murine mammary adenocarcinoma system.
    Purnell DM; Bartlett GL; Kreider JW; Biro TG; Kontra J
    Cancer Res; 1979 Dec; 39(12):4838-42. PubMed ID: 498111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
    Elliott WL; Roberts BJ; Howard CT; Leopold WR
    Cancer Res; 1994 Aug; 54(16):4412-8. PubMed ID: 8044790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of interleukin-12 against murine bladder cancer.
    Eto M; Harada M; Tamada K; Tokuda N; Koikawa Y; Nakamura M; Nomoto K; Naito S
    J Urol; 2000 May; 163(5):1549-52. PubMed ID: 10751886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.